Pages that link to "Q72161523"
Jump to navigation
Jump to search
The following pages link to Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations (Q72161523):
Displaying 50 items.
- A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1 (Q24324095) (← links)
- Energy metabolism in neuroblastoma and Wilms tumor (Q26770341) (← links)
- Wilms' tumor: biology, diagnosis and treatment (Q26862181) (← links)
- Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration (Q28083988) (← links)
- Apoptosis, cancer and the p53 tumour suppressor gene (Q28611432) (← links)
- Molecular characterization of Wilms' tumor from a resource-constrained region of sub-Saharan Africa (Q30449310) (← links)
- Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour (Q33772549) (← links)
- Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study (Q33893718) (← links)
- Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours (Q33919211) (← links)
- Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network (Q33961864) (← links)
- Wilms tumour: diagnosis and treatment (Q33997742) (← links)
- Principles of Wilms' tumor biology (Q34031394) (← links)
- Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors (Q34145842) (← links)
- Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers (Q34235576) (← links)
- TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia (Q34338441) (← links)
- Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation (Q34428960) (← links)
- Genetic changes of two Wilms tumors with anaplasia and a review of the literature suggesting a marker profile for therapy resistance (Q34749817) (← links)
- Analysis of wilms tumors using SNP mapping array-based comparative genomic hybridization. (Q34841380) (← links)
- Molecular epidemiology of smoking and lung cancer (Q34935883) (← links)
- MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation (Q35071303) (← links)
- Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene (Q35095712) (← links)
- Clinical and biologic significance of nuclear unrest in Wilms tumor (Q35113842) (← links)
- Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour (Q35163343) (← links)
- The yin and yang of kidney development and Wilms' tumors (Q35173260) (← links)
- The Wnt signaling pathway in solid childhood tumors (Q35212566) (← links)
- Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of beta catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy (Q35588287) (← links)
- Management of Wilms' tumour: current practice and future goals (Q35618789) (← links)
- Metanephric adenofibroma in a 10-year-old boy: report of a case and review of the literature (Q35632404) (← links)
- Multiple mechanisms of MYCN dysregulation in Wilms tumour (Q35740193) (← links)
- Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development (Q35753374) (← links)
- Tumors associated with p53 germline mutations: a synopsis of 91 families. (Q35765327) (← links)
- Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome. (Q35773597) (← links)
- The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein. (Q35782290) (← links)
- Analyzing the gene expression profile of anaplastic histology Wilms' tumor with real-time polymerase chain reaction arrays (Q35801567) (← links)
- Stratification of Wilms tumor by genetic and epigenetic analysis (Q35987087) (← links)
- A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier (Q36115568) (← links)
- Wilms' tumour: connecting tumorigenesis and organ development in the kidney (Q36234726) (← links)
- p53 protein expression in nephroblastomas: a predictor of poor prognosis (Q36294933) (← links)
- MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours. (Q36392072) (← links)
- Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour (Q36475859) (← links)
- Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor (Q36556427) (← links)
- SKCG-1: a new candidate growth regulatory gene at chromosome 11q23.2 in human sporadic Wilms tumours (Q36614238) (← links)
- Wilms tumor (Q36661062) (← links)
- Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. (Q36709112) (← links)
- Cystatin C as a p53-inducible apoptotic mediator that regulates cathepsin L activity (Q36746295) (← links)
- Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic review (Q37146691) (← links)
- Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (Q37307376) (← links)
- Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor. (Q37437735) (← links)
- Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor. (Q37639483) (← links)
- Candidate genes and potential targets for therapeutics in Wilms’ tumour (Q37790163) (← links)